Cox R J, Brokstad K A, Zuckerman M A, Wood J M, Haaheim L R, Oxford J S
Department of Medical Microbiology, London Hospital Medical College, Whitechapel, UK.
Vaccine. 1994 Aug;12(11):993-9. doi: 10.1016/0264-410x(94)90334-4.
The enzyme-linked immunospot assay was used to examine the humoral immune response in 15 healthy volunteers immunized with either split or subunit inactivated trivalent influenza vaccine containing A/Beijing/353/89 (H3N2), A/Taiwan/1/86 (H1N1) and B/Yamagata/16/88. The rapidity of the individual B-cell and serum antibody response was examined in lymphocyte and serum samples collected at various time intervals after vaccination. A rapid serological response was detected with increases in antibody titre detected in the majority of volunteers by 7-8 days postvaccination. Influenza-specific plasma cells were detected as early as 4 days postvaccination, higher numbers of IgA and IgG antibody-secreting cells (ASC) were observed which peaked at 7-8 days postvaccination. The number of ASCs then declined, with low numbers of cells detected at 11 days postvaccination. Influenza-specific IgA ASCs were predominantly of the IgA1 subclass. This rapid immune response may have a bearing on future vaccination policies of unimmunized 'at risk groups' in times of high influenza activity.
采用酶联免疫斑点试验检测15名健康志愿者接种含A/北京/353/89(H3N2)、A/台湾/1/86(H1N1)和B/山形/16/88的裂解或亚单位灭活三价流感疫苗后的体液免疫反应。在接种疫苗后的不同时间间隔采集淋巴细胞和血清样本,检测个体B细胞和血清抗体反应的速度。接种疫苗后7 - 8天,大多数志愿者的抗体滴度升高,检测到快速的血清学反应。接种疫苗后4天即可检测到流感特异性浆细胞,观察到较高数量的分泌IgA和IgG抗体的细胞(ASC),在接种疫苗后7 - 8天达到峰值。然后ASC数量下降,接种疫苗后11天检测到的细胞数量较少。流感特异性IgA ASC主要为IgA1亚类。这种快速免疫反应可能会影响流感高发期未免疫“高危人群”未来的疫苗接种政策。